Address Information


E-mail CVBT

Investor Inquiry

Scientific Inquiry

General and Press Inquiries

Clinical Trial Inquiries



   
Contact CVBT  
 

Thank you for your interest in CardioVascular BioTherapeutics, Inc.


See our Corporate Address information.


Select one of the following topics and e-mail CVBT:

Investor Inquiries

Scientific Inquiries

General and Press Inquiries

Clinical Trial Inquiries


Or reach a specific CVBT department or service:

Investor Relations

Shareholder Services

Public Relations

Legal

Accounting

 

 

 

 

 

 

 

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease


11/13/2008
CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate


9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial


7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates